SNM practice guideline for sodium18F-fluoride PET/CT bone scans 1.0

Journal of Nuclear Medicine

Volumn 51, Issue 11, 2010, Pages 1813-1820

  Segall, George ^a   Delbeke, Dominique ^b   Stabin, Michael G ^b   Even Sapir, Einat ^c   Fair, Joanna ^d   Sajdak, Rebecca ^e   Smith, Gary T ^f  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORINE 18; FLUORODEOXYGLUCOSE F 18;

ARTHRITIS; AVASCULAR NECROSIS; BACKACHE; BONE PAIN; BONE SCINTISCANNING; CHILD ABUSE; COMPUTER ASSISTED TOMOGRAPHY; HEALTH CARE PERSONNEL; HUMAN; INTERPERSONAL COMMUNICATION; JAW OSTEONECROSIS; JOINT PROSTHESIS; MEDICAL DOCUMENTATION; METABOLIC BONE DISEASE; OSTEOMYELITIS; PAGET BONE DISEASE; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; RADIATION SAFETY; RESPONSIBILITY; REVIEW;

BONE AND BONES; BREAST FEEDING; DOCUMENTATION; FLUORINE RADIOISOTOPES; HEALTH EDUCATION; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGE PROCESSING, COMPUTER-ASSISTED; INFECTION CONTROL; NUCLEAR MEDICINE; POSITRON-EMISSION TOMOGRAPHY; QUALITY CONTROL; QUALITY IMPROVEMENT; RADIOPHARMACEUTICALS; RESEARCH DESIGN; SAFETY; SOCIETIES, SCIENTIFIC; SODIUM FLUORIDE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79851484267     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.110.082263     Document Type: Review

References (44)

1. Sodium fluoride F 18 injection investigator's brochure. National Cancer Institute Cancer Imaging Program Web site. Available at: http://imaging.cancer. gov/images/Documents/bccff836-d508-4ceb-b22a-894f563cc352/NaF-IB-Edition1- 072808.pdf. Released August 2008. Accessed August 26, 2010.
2. Hoh C, Hawkins RA, Dahlbom M, et al. J Comput Assist Tomogr. 1993;17:34-41.
3. Brenner W, Bohuslavizki KH, Eary JF. PET imaging of osteosarcoma. J Nucl Med. 2003;44:930-942. (Pubitemid 40003746)
4. 18F-fluoride PET/CT. J Nucl Med. 2004;45:272-278.
5. 18F-fluoride PET/CT. J Nucl Med. 2006;47:287-297.
6. Even-Sapir E, Mishani E, Flusser G, Metser U. 18F-fluoride positron emission tomography and positron emission tomography/computed tomography. Semin Nucl Med. 2007;37:462-469. (Pubitemid 47505220)
7. 18F-fluoride in bone imaging with emphasis on prostate and breast. Semin Nucl Med. 2006;36:73-92.
8. Schirrmeister H, Guhlmann A, Kotzerke J, et al. Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography. J Clin Oncol. 1999;17:2381-2389. (Pubitemid 29368236)
9. 18F-labeled NaF PET in newly diagnosed lung cancer. J Nucl Med. 2001;42:1800-1804.
10. Schirrmeister H, Buck A, Guhlmann A, Reske SN. Anatomical distribution and sclerotic activity of bone metastases from thyroid cancer assessed with F-18 sodium fluoride positron emission tomography. Thyroid. 2001;11:677-683. (Pubitemid 32701589)
11. Schirrmeister H. Detection of bone metastases in breast cancer by positron emission tomography. Radiol Clin North Am. 2007;45:669-676. (Pubitemid 47238392)
12. Dasgeb B, Mulligan MH, Kim CK. The current status of bone scintigraphy in malignant diseases. Semin Musculoskelet Radiol. 2007;11:301-311. (Pubitemid 351415484)
13. 18F fluoride PET-CT: a comparative study. Eur J Nucl Med Mol Imaging. 2008;35:1766-1774.
14. Beheshti M, Langsteger W, Fogelman I. Prostate cancer: role of SPECT and PET in imaging bone metastases. Semin Nucl Med. 2009;39:396-407.
15. 18F-fluoride: applying new technology to an old tracer. J Nucl Med. 2008;49:68-78.
16. Ben-Haim S, Israel O. Breast cancer: role of SPECT and PET in imaging bone metastases. Semin Nucl Med. 2009;39:408-415.
17. Chua S, Gnanasegaran G, Cook GJR. Miscellaneous cancers (lung, thyroid, renal cancer, myeloma, and neuroendocrine tumors): role of SPECT and PET in imaging bone metastases. Semin Nucl Med. 2009;39:416-430.
18. 18F-FDG PET/CT. Eur J Nucl Med Mol Imaging. 2009;36:1807-1812.
19. 18F-fluoride positron-emission tomography-computed tomography. J Pediatr Orthop. 2007;27:90-93.
20. Lim R, Fahey FH, Drubach LA, Connolly LP, Treves ST. Early experience with fluorine-18 sodium fluoride bone PET in young patients with back pain. J Pediatr Orthop. 2007;27:277-282. (Pubitemid 46573178)
21. 18F]fluoride positron-emission tomography/computed tomography on patients with unclear foot pain. Skeletal Radiol. 2010;39:987-997.
22. Drubach LA, Sapp MV, Laffin S, Kleinman PK. Fluorine-18 NaF PET imaging of child abuse. Pediatr Radiol. 2008;38:776-779.
23. 18F-NaF PET. Radiology. 2010;255:174-181.
24. Dasa V, Adbel-Nabi H, Anders MJ, Mihalko WM. F-18 fluoride positron emission tomography of the hip for osteonecrosis. Clin Orthop Relat Res. 2008;466:1081-1086.
25. 18F-fluoride positron emission tomography. Knee Surg Sports Traumatol Arthrosc. 2009;17:53-59.
26. Raje N, Woo SB, Hande K, et al. Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw. Clin Cancer Res. 2008;14:2387-2395. (Pubitemid 351551072)
27. Wilde F, Steinhoff K, Frerich B, et al. Positron-emission tomography imaging in the diagnosis of bisphosphonate-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107:412-419.
28. 18F]-fluoride positron emission tomography for imaging condylar hyperplasia. Br J Oral Maxillofac Surg. 2009;47:196-199.
29. Saridin CP, Raijmakers PG, Kloet RW, Tuinzing DB, Becking AG, Lammertsma AA. No signs of metabolic hyperactivity in patients with unilateral condylar hyperactivity: an in vivo positron emission tomography study. J Oral Maxillofac Surg. 2009;67:576-581.
30. 18F-fluoride PET: a prospective study. J Nucl Med. 2009;50:1808-1814.
31. Installé J, Nzeusseu A, Bol A, Depresseux G, Devogelaer JP, Lonneux M. 18F-fluoride PET for monitoring therapeutic response in Paget's disease of bone. J Nucl Med. 2005;46:1650-1658. (Pubitemid 46211589)
32. Brenner W, Vernon C, Conrad EU, Eary JF. Assessment of the metabolic activity of bone grafts with 18F-fluoride PET. Eur J Nucl Med Mol Imaging. 2004;31:1291-1298. (Pubitemid 39222493)
33. 18F] fluoride PET: a pilot study. Mol Imaging Biol. 2008;10:288-293.
34. Ullmark G, Sörensen J, Nilsson O. Bone healing of severe acetabular defects after revision arthroplasty: a clinical positron emission tomography study of 7 cases. Acta Orthopaedica. 2009;80:179-183.
35. Pecherstorfer M, Schilhing T, Janisch S, et al. Effect of clodronate treatment on bone scintigraphy in metastatic breast cancer. J Nucl Med. 1993;34:1039-1044. (Pubitemid 23191316)
36. 99mTc-methylene diphosphonate bone scanning. J Nucl Med. 2001;42:1359-1363.
37. Boellaard R, O'Doherty MJ, Weber WA, et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging. 2010;37:181-200.
38. Hoegerle S, Juengling F, Otte A, Altehoefer C, Moser EA, Nitzsche EU. Combined FDG and [F-18]fluoride whole body PET: a feasible two-in-one approach to cancer imaging? Radiology. 1998;209:253-258.
39. Brunkhorst T, Boerner AR, Bergh S, Otto D, Gratz FW, Knapp WH. Pretherapeutic assessment of tumour metabolism using a dual tracer PET technique. Eur J Nucl Med Mol Imaging. 2002;29:1416. (Pubitemid 44392226)
40. 18F-FDG PET/CT scan for evaluation of malignancy: results of the pilotphase study. J Nucl Med. 2009;50:501-505.
41. 18F-FDG and fluoride approach in PET/CT imaging: is there a clinical future? [letter]. J Nucl Med. 2010;51:165-167.
42. Radiation dose to patients from radiopharmaceuticals (addendum 3 to ICRP Publication 53): ICRP publication 106, approved by the Commission in October 2007. Ann ICRP. 2008;38:1-197.
43. Radiation dose to patients from radiopharmaceuticals (addendum 2 to ICRP publication 53): ICRP publication 80, approved by the Commission in September 1997. Ann ICRP. 1998;28:1-126.
44. Russell JR, Stabin MG, Sparks RB, Watson EE. Radiation absorbed dose to the embryo/fetus from radiopharmaceuticals. Health Phys. 1997;73:756-769. (Pubitemid 27444395)